Ironwood Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $787.37 million, with shareholders equity totaling $-97.19 million.
The company employs approximately 674 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Ironwood Pharmaceuticals Inc. reported $400.30 million in revenue, generating net income of $149.63 million.
Key financial metrics include a P/E ratio of 5.26, a price-to-book (P/B) ratio of -8.10, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker IRWD.